These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 63520)

  • 1. Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum.
    Tabor E; Gerety RJ; Smallwood LA; Barker LF
    J Immunol; 1977 Jan; 118(1):369-70. PubMed ID: 63520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of antibody to the "y" determinant of HBsAg in a chimpanzee carrier of HBsAg subtype "adw".
    Tabor E; Gerety RJ; Smallwood LA; Barker LF
    J Immunol; 1976 Nov; 117(5 Pt.2):2038-40. PubMed ID: 62804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous presence of HBsAg and anti-HBs in the serum of different subtypes (serological and immunofluorescent studies).
    Hess G; Arnold W; Koesters W; Biswas R; Hütteroth TH; zum Büschenfelde KH
    Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):143-51. PubMed ID: 333803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies].
    Manzillo G; Sagnelli E; Da Villa G; Maio G; Izzo CM; Felaco F; Filippini P; Buonocore S; Piccinino F
    Minerva Med; 1980 Oct; 71(42):3067-71. PubMed ID: 7266910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family infected with hepatitis B and with concurrently circulating HBsAg and heterotypic anti-HBs.
    Thijs JC; van Bergeijk L; Heijtink RA; Douwes AC; Meuwissen SG
    Hepatogastroenterology; 1984 Apr; 31(2):69-71. PubMed ID: 6724498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of hepatitis B antigen (HBsAg) and its related antibody (anti-HBs) in acute viral hepatitis].
    Giuliani G; Castelletti GC; Novara O; Paggi GC; Varetti G; Grillone W; Bosio G; Aggero S
    G Batteriol Virol Immunol; 1977; 70(7-12):197-214. PubMed ID: 615745
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
    Kato J; Hasegawa K; Torii N; Yamauchi K; Hayashi N
    Hepatology; 1996 Mar; 23(3):389-95. PubMed ID: 8617416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
    Carman WF; Van Deursen FJ; Mimms LT; Hardie D; Coppola R; Decker R; Sanders R
    Hepatology; 1997 Dec; 26(6):1658-66. PubMed ID: 9398013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different antibody responses against hepatitis B surface antigen among mouse strains transfected with mutant viral DNA.
    Hasegawa K; Joh R; Iizuka A; Naritomi T; Kanai N; Ogawa M; Torii N; Hayashi N
    J Gastroenterol; 2002; 37(12):1035-41. PubMed ID: 12522535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simultaneous occurrence in the serum of hepatitis B surface antigen (HBsAg) and antibodies against HBsAg (Anti-HBs) of different subtypes. (Serologic and fluorescence histologic studies)].
    Arnold W; Hess G; Meyer zum Büschenfelde KH; Kösters W; Biswas R; Strauch M; Knolle J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():405-7. PubMed ID: 70122
    [No Abstract]   [Full Text] [Related]  

  • 16. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
    Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
    Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of different methods of detection of HBsAg and of anti-HBs antibody. Criteria of choice for directed epidemiological surveys].
    Castagnari L; Gasparini V; Menini C
    Nuovi Ann Ig Microbiol; 1978; 29(3):223-32. PubMed ID: 754185
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of graft survival with host response to hepatitis B infection in patients with kidney transplants.
    London WT; Drew JS; Blumberg BS; Grossman RA; Lyons PJ
    N Engl J Med; 1977 Feb; 296(5):241-4. PubMed ID: 318732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver.
    Kojima M; Udo K; Takahashi Y; Yoshizawa H; Tsuda F; Itoh Y; Miyakawa Y; Mayumi M
    Gastroenterology; 1977 Oct; 73(4 Pt 1):664-7. PubMed ID: 330306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent.
    Kondo R; Feitelson MA; Strayer DS
    Gene Ther; 1998 May; 5(5):575-82. PubMed ID: 9797861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.